Sign in

CIK 0001840229

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$73,265
in 1 filing

Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Buell Jennifer −$73K Chief Executive Officer sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-01 Corvese Brian Director Grant or award +1,633 $10.95 $18K 54,770
2026-06-01 Corvese Brian Director Grant or award +1,444 $12.38 $18K 53,137
2026-03-02 Corvese Brian Director Grant or award +1,640 $10.90 $18K 51,693
2026-01-02 Corvese Brian Director Grant or award · Stock Option (Right to Buy) +5,395 5,395
2025-12-01 Corvese Brian Director Grant or award +1,612 $11.09 $18K 50,053
2025-09-09 Corvese Brian Director Grant or award · Stock Option (Right to Buy) +3,225 3,225
2025-09-02 Corvese Brian Director Grant or award +1,290 $13.86 $18K 48,441
2025-06-02 Corvese Brian Director Grant or award +2,494 $7.17 $18K 47,151
2025-03-03 Corvese Brian Director Grant or award +2,033 $8.79 $18K 44,657
2024-12-01 Corvese Brian Director Grant or award +24,400 $0.73 $18K 426,283
2024-09-03 Corvese Brian Director Grant or award +21,802 $0.82 $18K 405,296
2024-06-03 Corvese Brian Director Grant or award +17,967 $0.99 $18K 383,494
2024-03-01 Corvese Brian Director Grant or award +18,816 $0.95 $18K 365,527
2023-12-01 Corvese Brian Director Grant or award +17,188 $1.04 $18K 346,711
2023-09-01 Corvese Brian Director Grant or award +12,244 $1.46 $18K 329,523
2023-06-14 Corvese Brian Director Grant or award · Stock Option (Right to Buy) +37,500 37,500
2023-06-01 Corvese Brian Director Grant or award +10,157 $1.76 $18K 317,505
2023-03-01 Corvese Brian Director Grant or award +8,553 $2.09 $18K 307,348
2022-12-01 Corvese Brian Director Grant or award +6,849 $2.61 $18K 298,795
2022-09-15 Corvese Brian Director Grant or award +13,646 $2.62 $36K 13,646

Page 1 of 2 · 21 trades